Automate Your Wheel Strategy on NXGLW
With Tiblio's Option Bot, you can configure your own wheel strategy including NXGLW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NXGLW
- Rev/Share 1.3377
- Book/Share 0.7283
- PB 3.4051
- Debt/Equity 0.5074
- CurrentRatio 1.8817
- ROIC -0.4258
- MktCap 17758526.0
- FreeCF/Share -0.4533
- PFCF -5.1236
- PE -5.6488
- Debt/Assets 0.2532
- DivYield 0
- ROE -0.6338
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About NEXGEL, Inc. (NXGLW)
- IPO Date
- Website https://nexgel.com
- Industry Medical - Instruments & Supplies
- CEO Mr. Adam R. Levy
- Employees 19
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was founded in 1997 and is based in Langhorne, Pennsylvania.